Copyright © 2024 Research Nester. All Rights Reserved
Global Methotrexate Drug Market TOC
Growth Drivers
Challenges
The methotrexate drug market is expected to observe an attainable high CAGR during the forecast period, i.e., 2020-2028. The market is segmented by type, route of administration, application, end-users, distribution channel, and region. Among distribution channel segmentation, the hospital pharmacies segment is anticipated to grow significantly during the forecast period on account of growing numbers of registered cancer & autoimmune diseased patients worldwide, the prevalence of medical abortions, growing awareness about cancer diseases, and R&D initiatives resulting in advanced medications and drugs to cure the illness.
Growth Drivers
Growing awareness related to associated diseases and less toxicity compared to other treatments
An increase in the incidence of target diseases and rising awareness among the healthcare sector and the common public related to the drug, are the key factors that are driving the growth of the global methotrexate drug market.
Methotrexate was widely accepted among healthcare professionals for treating cancer as it was less toxic than the then used treatments. It has extensive use while performing chemotherapies on patients and in disease-modifying treatments for autoimmune illnesses. For its effectiveness, low-dose methotrexate is often preferred for first-line therapy of rheumatoid arthritis. The drug is widely popular for terminating pregnancies during the early stages and for treating ectopic pregnancies. CLICK TO DOWNLOAD SAMPLE REPORT
According to WHO, Cancer is the second foremost cause of death globally and is accountable for a probable 9.6 million deaths in 2018. Worldwide, about 1 in 6 deaths is owed to cancer.
Furthermore, initiatives taken by numerous government and private organizations to spread alertness about the target diseases, rise in disposable income and surge in healthcare facilities in developing countries, novel R&D inventiveness to create medications, technological innovations, and investments by major players are likely to boost the market growth during the forecast period.
Restraints
Side effects caused by the drug
Common side effects of consuming methotrexate might include hair loss, nausea, headaches, and skin pigmentation. The most common side effects which can have adverse effects include liver damage, kidney failure, and others. These effects might come up as market hindrances in the foreseeable future.
Further, strict government regulations in certain nations, lack of awareness, slow detection of the disease, and high costs involved in the treatments might also add as growth constraints for the overall methotrexate drug market.
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
2.9% |
|
Base Year Market Size (2024) |
USD 584.09 million |
|
Forecast Year Market Size (2037) |
USD 846.99 million |
|
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?